The challenge produced by familial homozygous hypercholesterolemia when treating premature coronary arterial disease in the young

Cardiology in the Young

Volumn 19, Issue 3, 2009, Pages 257-263

  Shankarappa, Ravindranath Khandenahalli ^a   Moorthy, Nagaraja ^a   Bhat, Seetharama P S ^a   Dwarakaprasad, Ramesh ^a   Nanjappa, Manjunath C ^a  

^a SRI JAYADEVA INSTITUTE OF CARDIOVASCULAR SCIENCES AND RESEARCH   (India)

Author keywords

Corneal arcing; Myocardial infarction; Premature atherosclerosis; Tendon xanthomas

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; EZETIMIBE; HEPARIN;

ADOLESCENT; ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CHILD; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; CORONARY STENT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HOMOZYGOSITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; INDIA; MALE; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

ADOLESCENT; ANGINA PECTORIS; CHILD; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; DRUG-ELUTING STENTS; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INDIA; MALE; RISK FACTORS; TREATMENT OUTCOME; XANTHOMATOSIS; YOUNG ADULT;

EID: 70349181069     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951109003989     Document Type: Article

References (13)

1. Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients. Am J Cardiol 1984; 54: 20-30.
2. Allen JM, Thompson GR, Myant NB, Steiner R, Oakley CM. Cardiovascular complications of homozygous familial hypercholesterolemia. Br Heart J 1980; 44: 361-368.
3. Mabuchi H, Koizumi J, Shimizu M, et al. Development of coronary heart disease in familial hypercholesterolemia. Circulation 1989; 79: 225-332.
4. Goldstein JL, Brown MS. Familial hypercholesterolemia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds). The Metabolic Basis of Inherited Disease, 5 edn. McGraw-Hill Book Co, New York, 1983, p 672.
5. Thompson OR, Lowenthal R, Myant NB. Plasma exchange in the management of homozygous familial hypercholesterolemia. lancet 1975; 1: 1208-1211.
6. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low-density lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolernia. N Engl J Med 1984; 311: 1658-1664.
7. Starzl TE, Chase HP, Ahrens EH Jr, et al. Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg 1983; 198: 273-283.
8. WHO. Human Genetic Program. Familial Hypercholesterolemia. Report of a WHO consultation. WHO/HGN/FH/CONS/987 Paris; October 1997.
9. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992: 340: 1111-1115.
10. Stroes E, Kastelein JJP, Cosentino F, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997; 99: 41-46.
11. Virkola K, Pesonen E, Åkerblom HK, et al. Cholesterol and carotid artery wall in children and adolescents with familial hypercholesterolemia: A controlled study by ultrasound. Acta Pediarr 1997; 86: 1203-1207.
12. Wiegman A, Rodenburg J, Gort J, et al. B-mode ultrasound measurements of carotid artery walls in children with molecular proven familial hypercholesterolemia and their unaffected siblings. Circulation 2001; 104 (Suppl II): II-526. Abstract.
13. Mabuchi H, Tatami R, Haba T, et al. Homozygous familial hypercholesterolemia in Japan. Am J Med 1978; 65: 290-297.